Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05107635 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Inappropriate Sinus Tachycardia Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 11 months later Jan 2027 → Jan 2030
See other at-risk trials from AtriCure, Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Jan 2027 to Jan 2030
    • Site details revised at 2 of 15 sites
    • Eligibility criteria expanded, about 4 words
  2. Minor Trial sites expanded: 12 → 15 locationsv8
  3. Minor Study sites: 10 to 12v7
  4. Minor 2 versions Re-verified since Mar 25, 2025, no change to tracked fieldsv5-v6
  5. Minor Trial status: Enrolling by Invitation to Recruiting
    • Study sites revised (10)
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Primary endpoint revisedv3 Show 4 more changesShow less
    • Trial status: Recruiting to Enrolling by Invitation
    • Study sites: 1 to 10
    • Interventions: AtriCure Isolator® Synergy™ Surgical Ablation System (Device) to AtriCure Commercially Available Devices (Device)
    • Eligibility criteria shortened, about 19 words
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2022 to Mar 1, 2022
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
9 trials monitored
See 1 trial at risk
The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
Trial Details
NCT Number NCT05107635
Lead Sponsor AtriCure, Inc.
Conditions
(from sponsor)
Inappropriate Sinus Tachycardia, Postural Tachycardia Syndrome
Related terms Postural Orthostatic Tachycardia Syndrome
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov